Register
US Food and Drug Administration outdoor campus sign with FDA and HHS seals

REGULATORY

7 May 2026

Is This ADC the Chemo Killer TNBC Needed?

Dato-DXd nears US approval for first-line metastatic TNBC, backed by a landmark 5-month survival gain over chemotherapy

Outdoor FDA sign at U.S. Department of Health and Human Services headquarters

REGULATORY

23 Apr 2026

The End of the Chemo Era for Bladder Cancer?

Regulators grant priority review to an antibody-drug and immunotherapy regimen intended to reduce recurrence in surgical patients

Pharmaceutical cleanroom with technician operating lab equipment

MARKET TRENDS

2 Apr 2026

ADC Outsourcing Market Tops $2B as US Capacity Surges

US-based manufacturers dominate a sector reshaped by 780 active trials and accelerating reshoring investment

Researcher pipetting sample on microscope stage in lab

INSIGHTS

30 Mar 2026

Cancer Diagnostics Haven't Kept Up with ADC Science

A 2026 review urges quantitative proteomics to replace IHC and improve patient selection for ADC cancer therapies

Starpharma and Genentech logos displayed outside biotechnology company offices

INNOVATION

25 Mar 2026

ADCs Have a Toxicity Problem. Dendrimers Don't.

Starpharma's DEP platform targets ADC toxicity at the delivery level, with a Genentech deal signaling big pharma's interest

Doctor holding colon model and blue awareness ribbon

INNOVATION

20 Mar 2026

Can a Two-Key Lock Crack Colorectal Cancer?

Promatix's AND-gate molecule demonstrated 50-fold potency gains over standard therapy in early colorectal cancer models

topics on the agenda

CLEAR OR CROWDED? FTO STRATEGY FOR NEXT GENERATION ADCS

DAY 1: undefined

09:30 - 09:55

OBTAINING BROAD PATENTS IN BIOTECH

DAY 1: undefined

11:30 - 11:55

ACCELERATING ADC LINKER AND PAYLOAD DESIGN THROUGH INTEGRATED COMPUTATIONAL INTELLIGENCE

DAY 1: undefined

12:00 - 12:25

View more topics

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.